Online consultations with MCSC doctors n. a. A. S. Loginov

Accompanying and supportive therapy in oncology (Electronic educational course, 36 hours)

Category of trainees: medical specialists in the areas of: Oncology, Surgery, Urology, Hematology, Rheumatology, Allergy & immunology, Hematology, Toxicology, Coloproctology, health Organization and public health, Gastroenterology, internal medicine, Geriatrics, Clinical pharmacology, Pulmonology, Infectious diseases, General medical practice (family medicine), Transfusion, Nursing care, "Medical care".

The complexity of the program: 36 academic hours.

Form of training: distance learning by means of an electronic educational environment with the use of interactive communication technologies.

Relevance:

The amount of knowledge currently accumulated in the field of cancer treatment is enormous. The number of new cytostatics and targeted drugs has increased significantly, and many treatment regimens are used for almost every known malignant tumor. However, it should be remembered that the total effect is determined by the balance between antitumor efficacy and toxicity of therapy. If the patient dies from toxicity, stops therapy due to intolerable side effects, or (most importantly in the case of palliative care) gains survival at the cost of severe toxicity, the overall effectiveness of treatment is much less obvious.

Prevention and control of complications of antitumor treatment is called accompanying or supportive therapy (supportive care).

Today, accompanying therapy occupies an essential place in the complex treatment of cancer patients. It is proved that the quality and life expectancy of patients depend on adequately conducted accompanying therapy. The tasks facing the accompanying therapy include:

- ensuring the normal pharmacokinetics of chemotherapy drugs;

- protection of organs and tissues from the toxic effects of antitumor drugs and their metabolites;

- maintenance of homeostasis and basal metabolism;

- ensuring the functioning of all vital systems of the body;

- prevention of infections,

- treatment of complications of the underlying disease and caused by chemotherapy.

The accompanying therapy should be as intensive as possible to ensure that the chemotherapy can be carried out in full and at the right time.

The purpose of the program: to familiarize doctors with the algorithms and principles of accompanying treatment aimed at combating the most frequent, and often the most dangerous complications of drug therapy, to improve the knowledge of specialists on topical issues of accompanying and supportive therapy of cancer patients: management of cancer patients with infectious diseases, anemia syndrome. Prevention and treatment of nausea and vomiting

Modern methods of analgesic therapy and palliative care, nutritional support, features of the use of osteomodifying drugs, high-tech endoscopic operations in the surgical treatment of oncological diseases.

As part of the course, we:

  1. We will analyze the issues of managing an oncological patient with infectious diseases and anemic syndrome.
  2. Consider the methods of prevention and treatment of nausea and vomiting.
  3. Consider the features of the use of osteomodifying drugs.
  4. We will tell you about modern techniques of high-tech endoscopic operations in the surgical treatment of oncological diseases.
  5. Let's analyze the complications that occur with immunotherapy, mucositis, diarrhea.
  6. Let's analyze the different types of toxicity
  7. We will discuss the issues of analgesic therapy and palliative care.
  8. Let's analyze the current issues of nutritional support.
  9. We will discuss vascular access during drug therapy, nfusion and allergic reactions.

Speakers of the professional development cycle:

1. Gronskaya Yulia Aleksandrovna, oncologist, MEDSI clinic St. Petersburg;

2. Marina A. Kogay, PhD, Associate Professor of the NC and OC of Gastroenterology and Hepatology of St. Petersburg State University, dietitian of the Clinic of Oncological Solutions at the Higher School of Oncology "Luch»;

3. Kurmukov Ildar Anvarovich, Candidate of Medical Sciences, Senior researcher of the Department of General Oncology, anesthesiologist-resuscitator of the State Medical Institution of the Moscow State Medical Center named after A. S. Loginov DZM

4. Ekaterina A. Kushnareva, Ph. D., cardiologist at the V. A. National Research Medical Center.  Almazova", general practitioner, cardiologist of the Clinic of Oncological Solutions at the Higher School of Oncology "Luch»;

5. Matorina Olga Gennadyevna, oncologist of the Department of Palliative Care of the Multidisciplinary Center of Palliative Care of the DZM;

6. Alexey Rumyantsev, oncologist, N. N. Blokhin National Research Medical Center of Oncology»;

7. Stepanova Maria Leonidovna, Head of the Department of antitumor therapy (day hospital) in the clinic of oncological Solutions at the Higher School of Oncology "Luch»;

8. Shilo Polina Sergeevna, oncologist of the clinic of oncological solutions at the Higher School of Oncology "Luch", Program Director of the Higher School of Oncology.

Working program of the course

Sign up for the course and complete the training

 

GBUZ Moscow Clinical Scientific Center named after Loginov MHD Social network presence: